Modeling long-term health outcomes of patients with cystic fibrosis homozygous for <i>F508del-CFTR</i> treated with lumacaftor/ivacaftor - Concepedia

Concepedia

Publication | Open Access

Modeling long-term health outcomes of patients with cystic fibrosis homozygous for <i>F508del-CFTR</i> treated with lumacaftor/ivacaftor

DOI Full Paper Access

29

Citations

34

References

2019

Year

Jaime Rubin, Lasair O’Callaghan, C. Pelligra, Michael W. Konstan, Alexandra Ward, Jack K. Ishak, Conor Chandler, Theodore G. Liou

Therapeutic Advances in Respiratory Disease

Abstract

Lumacaftor/ivacaftor is projected to increase survival for patients with CF. Initiation at an early age and treatment persistence result in further increments in projected survival.

References

	Year	Citations

Page 1